Cargando…
SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer via regulation of IFN-γ/STAT1 axis
INTRODUCTION: Colorectal cancer (CRC) is largely refractory to currently available immunotherapies such as blockade of programmed cell death protein-1 (PD-1). RESULTS: In this study, we identified SPATA2 and its protein partner CYLD as novel regulators of CXC-ligand 10 (CXCL10), a T-cell-attractant...
Autores principales: | Tan, Tze Guan, Zybina, Yulia, McKenna, Cooper, Olow, Aleksandra, Rukmini, Subhadra Jayaraman, Wong, Michael Thomas, Sadekova, Svetlana, Chackerian, Alissa, Bauché, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756846/ https://www.ncbi.nlm.nih.gov/pubmed/36531014 http://dx.doi.org/10.3389/fonc.2022.1016307 |
Ejemplares similares
-
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016) -
SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016) -
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions
por: Bauché, David, et al.
Publicado: (2020) -
Mutation of SPATA7 in a family with autosomal recessive early-onset retinitis pigmentosa
por: Kannabiran, Chitra, et al.
Publicado: (2012) -
Compound heterozygous SPATA5 variants in four families and functional studies of SPATA5 deficiency
por: Puusepp, Sanna, et al.
Publicado: (2018)